| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/02/2013 | CN102846625A Stable valsartan, amlodipine and hydrochlorothiazide pharmaceutical composition and preparation method thereof |
| 01/02/2013 | CN102846624A Compound telmisartan hydrochlorothiazide pharmaceutical composition and preparation method thereof |
| 01/02/2013 | CN102846619A Uses of DPP-IV inhibitors |
| 01/02/2013 | CN102846611A Use of Scriptaid in preparation of medicines for treating traumatic brain injury diseases |
| 01/02/2013 | CN102846609A Synthesis method for antihypertensive agent isradipine and preparation of isradipine |
| 01/02/2013 | CN102846608A Pharmaceutical composition containing amlodipine and atorvastatin calcium, and preparation method thereof |
| 01/02/2013 | CN102846598A Application of coumarin in preparing formation inhibitors of advanced glycation end products (AGEs) |
| 01/02/2013 | CN102846595A Application of flavonoid compound WX-03 in relaxation of vascular smooth muscles |
| 01/02/2013 | CN102846580A Application of rifampicin capsule in preparation of pharmaceutical for treating hemorrhoids |
| 01/02/2013 | CN102846579A Valsartan medicinal capsule and preparation method thereof |
| 01/02/2013 | CN102846575A Nifedipine sustained release tablet and preparation method thereof |
| 01/02/2013 | CN102846574A Nifedipine controlled release composition and preparation method thereof |
| 01/02/2013 | CN102846565A Preparation method of Levamlodipine besylate tablet |
| 01/02/2013 | CN102846561A Ozagrel sodium drug combination for injection |
| 01/02/2013 | CN102846557A Adenosine cyclophosphate freeze-drying preparation and preparation method thereof |
| 01/02/2013 | CN102846456A Skin scraper with skin care liquid |
| 01/02/2013 | CN102846113A Mulberry leaf health care pillow core and preparation method thereof |
| 01/02/2013 | CN102845754A Ginger extract and preparation method thereof |
| 01/02/2013 | CN102845690A Hawthorn freeze-dried whole fruit and preparation method thereof |
| 01/02/2013 | CN102266567B Radix scutellariae extractive phospholipid complex, and preparation method and purpose thereof |
| 01/02/2013 | CN102228472B Reagent for causing targeting effect of marrow mesenchymal stem cells on myocardial infarction focus, and preparation method thereof |
| 01/02/2013 | CN102178697B Compound leech capsule and preparation method thereof |
| 01/02/2013 | CN102153543B Maleate salts of a quinazoline derivative useful as an antiangiogenic agent |
| 01/02/2013 | CN102120009B Prunella vulgaris capsule capable of stabilizing blood pressure |
| 01/02/2013 | CN102068426B New application of Ginkgolide B derivative in medicament preparation |
| 01/02/2013 | CN102050864B Transplanted wild ginseng ginsenoside B as well as extraction method and medical application thereof |
| 01/02/2013 | CN102001971B N-(4-guanidyl butyl) syringoylagmatine derivatives and pharmaceutical applications thereof |
| 01/02/2013 | CN101843627B Application of dihydrophenanthrene glycoside compound in preparing medicines for preventing and curing cardiovascular and cerebrovascular diseases |
| 01/02/2013 | CN101830889B 嘧啶衍生物 Pyrimidine derivatives |
| 01/02/2013 | CN101775348B Health-care vinegar, brewing method and application in preventing cardiovascular diseases thereof |
| 01/02/2013 | CN101745009B Method for extracting ginseng, dwarf lilyturf tuber and schisandra chinensis and preparation thereof |
| 01/02/2013 | CN101745008B Extraction method of ginseng, ophiopogon root and shiandra and preparation thereof |
| 01/02/2013 | CN101744993B Extraction method for ginseng, ophiopogon root and schisandra chinensis and preparation thereof |
| 01/02/2013 | CN101683526B Pharmaceutical composition containing angiotensin II receptor antagonist, B vitamins and gingo biloba extract |
| 01/02/2013 | CN101675036B Dual-acting benzoimidazole antihypertensive agents |
| 01/02/2013 | CN101671388B Blood brain barrier penetrable erythropoietin (EPO) and application thereof |
| 01/02/2013 | CN101632783B Application of Chinese medicinal composition in preparing medicament for treating cor pulmonale |
| 01/02/2013 | CN101590124B Application of traditional Chinese medicine composition in preparing medicament for improving prognosis of myocardial infarction |
| 01/02/2013 | CN101553244B Treatment for intimal hyperplasia and related conditions |
| 01/02/2013 | CN101480381B Coenzyme Q10 pharmaceutical composition |
| 01/02/2013 | CN101228149B Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors |
| 01/02/2013 | CN101102755B Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure |
| 01/01/2013 | US8344003 2-pyridinecarboxamide derivatives |
| 01/01/2013 | US8343996 Azaquinolinone derivatives and uses thereof |
| 01/01/2013 | US8343988 Inhibitors of histone deacetylase |
| 01/01/2013 | US8343932 Protease-sensitive site in apolipoprotein A1, therapeutic and diagnostic implications |
| 01/01/2013 | US8343921 Method for treating myocardial ischemia |
| 01/01/2013 | US8343920 Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds |
| 01/01/2013 | US8343763 Heterocyclic derivatives as modulators of ion channels |
| 01/01/2013 | US8343549 Therapeutic uses of Dunaliella powder |
| 12/27/2012 | WO2012177847A2 Methods of dissolving blood clots and the like |
| 12/27/2012 | WO2012177741A1 Pcsk9-binding polypeptides and methods of use |
| 12/27/2012 | WO2012177658A2 Methods of treating and preventing staphylococcus aureus infections and associated conditions |
| 12/27/2012 | WO2012177618A1 Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto |
| 12/27/2012 | WO2012176009A1 Treatment and prevention of diseases related to oxidative stress |
| 12/27/2012 | WO2012175797A1 In vitro cardiovascular model |
| 12/27/2012 | WO2012175771A1 Phenol extract from heat-treated olive subproducts |
| 12/27/2012 | WO2012175745A1 Cell secreted proteins for the treatment of myocardial infarction |
| 12/27/2012 | WO2012175554A1 Prodrugs of (1s,9s)-9-[[(1s)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6h-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their use in transdermal therapeutic systems |
| 12/27/2012 | WO2012175018A1 Traditional chinese medicine composition for promoting nerve regeneration and preparation method and use thereof |
| 12/27/2012 | WO2012174856A1 Oral thrombin inhibitor and preparation method and medical use thereof |
| 12/27/2012 | WO2012124978A3 Pharmaceutical composition for treating ischemic diseases, containing conditioned medium obtained through three-dimensional cell culture as active ingredient |
| 12/27/2012 | US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 12/27/2012 | US20120329870 Methods for Treating or Preventing Restenosis and Other Vascular Proliferative Disorders |
| 12/27/2012 | US20120329867 Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for administration shortly after amiodarone discontinuation |
| 12/27/2012 | US20120329862 Novel compound having inhibitory effect on lipase |
| 12/27/2012 | US20120329855 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf |
| 12/27/2012 | US20120329852 Composition for preventing the occurrence of cardiovascular event in multiple risk patient |
| 12/27/2012 | US20120329848 Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
| 12/27/2012 | US20120329844 Valsartan salts |
| 12/27/2012 | US20120329834 Compounds for the treatment of mitochondrial diseases |
| 12/27/2012 | US20120329810 Imatinib mesylate oral pharmaceutical composition and process for preparation thereof |
| 12/27/2012 | US20120329808 Dihydrothieno pyrimidines as akt protein kinase inhibitors |
| 12/27/2012 | US20120329802 Metalloenzyme inhibitor compounds |
| 12/27/2012 | US20120329786 Compounds and therapeutic uses thereof |
| 12/27/2012 | US20120329784 Compounds and methods |
| 12/27/2012 | US20120329776 Heterocyclic compounds and uses thereof |
| 12/27/2012 | US20120329774 Thieno-pyridine derivatives as mek inhibitors |
| 12/27/2012 | US20120329762 Anti-thrombotic compounds |
| 12/27/2012 | US20120329759 Formulations and methods for vascular permeability-related diseases or conditions |
| 12/27/2012 | US20120329758 Combined Treatment Utilizing VB-201 |
| 12/27/2012 | US20120329757 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 12/27/2012 | US20120329734 Mixture and infusion or drink solution |
| 12/27/2012 | US20120329727 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2 |
| 12/27/2012 | US20120329718 Compositions and methods for treating atrial fibrillation |
| 12/27/2012 | US20120329717 Novel omega conotoxin peptides |
| 12/27/2012 | US20120329716 Yellow pea seed protein-derived peptides |
| 12/27/2012 | US20120329715 Glp-1, exendin-4, peptide analogs and uses thereof |
| 12/27/2012 | US20120329703 Potent and Selective Mediators of Cholesterol Efflux |
| 12/27/2012 | US20120328712 Carbon monoxide releasing rhenium compounds for medical use |
| 12/27/2012 | US20120328686 Pharmaceutical Composition Comprising miRNA-100 And Its Use in the Modulation Of Blood Vessel Growth and Endothelial Inflammation |
| 12/27/2012 | US20120328666 Oral delivery of peptide pharmaceutical compositions |
| 12/27/2012 | US20120328661 Coumarin compounds as receptor modulators with therapeutic utility |
| 12/27/2012 | US20120328636 Kdr peptides and vaccines comprising the same |
| 12/27/2012 | US20120328635 Chaperonin 10 variants |
| 12/27/2012 | US20120328628 Antibodies to conformationally trapped proteins |
| 12/27/2012 | US20120328627 Chemokine receptor antagonists and use thereof |
| 12/27/2012 | US20120328616 Human antigen binding proteins that bind to a complex comprising beta-klotho and an fgf receptor |
| 12/27/2012 | US20120328606 Methods Of Diagnosing And Treating Pulmonary Diseases Or Disorders |
| 12/27/2012 | US20120328584 Biological Pacemaker |